Nicotinamide prevents the effect of perinatal asphyxia on dopamine release evaluated with in vivo microdialysis 3 months after birth

Experimental Brain Research

Volumn 177, Issue 3, 2007, Pages 358-369

  Bustamante, Diego ^a   Morales, Paola ^a   Pereyra, Jorge Torres ^a   Goiny, Michel ^b   Herrera Marschitz, Mario ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dopamine; Microdialysis; Niacinamide; Perinatal asphyxia; Poly(ADP ribose) Polymerase (PARP); Rat; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; BRAIN MONOAMINE; DEXAMPHETAMINE; DOPAMINE; HOMOVANILLIC ACID; NICOTINAMIDE; POTASSIUM CHLORIDE; POTASSIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LABORATORY TEST; MALE; METABOLITE; MICRODIALYSIS; MONITORING; NEOSTRIATUM; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL ASPHYXIA; PRIORITY JOURNAL; RANDOMIZATION; RAT; SIBLING; UTERUS HORN; WEANING;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTROCHEMISTRY; FEMALE; MALE; MICRODIALYSIS; NEOSTRIATUM; NIACINAMIDE; POTASSIUM CHLORIDE; PREGNANCY; RATS; RATS, WISTAR; TIME FACTORS; VITAMIN B COMPLEX;

EID: 33847153455     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-006-0679-0     Document Type: Article

References (68)

1. Amé J-C, Spenlehauer C, de Murcia G (2004) The PARP superfamily. BioEssays 26:882-893
2. Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dimagl U, Szabo C, Endres M (2001) Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in vitro and in vivo models of stroke. Int J Mol Med 7:255-260
3. Akhter W, Ashraf QM, Zanelli SA, Mishra OP, Delivoria-Papadopoulus M (2001) Effect of graded hypoxia on cerebral cortical genomic DNA fragmentation in newborn piglets. Biol Neonate 79:187-193
4. Andersson K, Blum M, Chen Y, Eneroth P, Gross J, Herrera-Marschitz M, Bjelke B, Bolme P, Diaz R, Jamison L, Loidl F, Ungethüm U, Åström G, Ögren SÖ (1995) Perinatal asphyxia increases bFGF mRNA levels and DA cell body number in mesencephalon of rats. NeuroReport 6:375-378
5. Barkovich AJ (2006) MR imaging of the neonatal brain. Neuroimaging Clin N Am 16:117-135
6. Berger NA (1985) Poly (ADP-ribose) in the cellular response to DNA damage. Radiat Res 1001:4-15
7. Berger R, Garnier Y (2000) Perinatal brain injury. J Perinat Med 28:261-285
8. Boksa P, El Khodor BP (2003) Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disordes. Neurosci Biobehav Rev 27:91-101
9. Bustamante D, Zhi-Bing Y, Castel MN, Johansson S, Goiny M, Terenius L, Hökfelt T, Herrera-Marschitz M (2002) Effect of repeated methamphetamine treatment on neurotransmiter release in substantia nigra and neostriatum of the rat. J Neurochem 83:645-654
10. Bustamante D, Goiny M, Åström G, Gross J, Andersson K, Herrera-Marschitz M (2003) Nicotinamide prevents the long-term effects of perinatal asphyxia on basal ganglia monoamine systems in the rat. Exp Brain Res 148:227-232
11. Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW (1988) Amphetamine-induced release in the rat striatum: an in vivo microdialysis study. J Neurochem 50:346-355
12. Calabresi P, Centonze D, Bernardi G (2000) Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology 55:1249-1255
13. Carter BS, Haverkamp AD, Merenstein GB (1993) The definition of acute perinatal asphyxia. Clin Perinatol 20:287-303
14. Chen Y, Ögren SÖ, Bjelke B, Bolme P, Eneroth P, Gross J, Loidl F, Herrera-Marschitz M, Andersson K (1995) Nicotine treatment counteracts perinatal-induced changes in the mesostriatal/limbic dopamine systems and in motor behaviour in the four-week-male rat. Neuroscience 68:531-538
15. Chen Y, Herrera-Marschitz M, Bjelke B, Blum M, Gross J, Andersson K (1997a) Perinatal asphyxia-induced changes in rat brain tyrosine-hydroxylase- immunoreactive cell body number: effects of nicotine treatment. Neurosci Lett 221:77-80
16. Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G (1997b) Perinatal asphyxia induces long-term changes in dopamine D1, D2 and D3 receptor binding in the rat brain. Exp Neurol 146:74-80
17. Chen Y, Engidawork E, Loidl F, Dell'Anna E, Goiny M, Lubec G, Andersson K, Herrera-Marschitz M (1997c) Short- and long-term effects of perinatal asphyxia on monoamine, amino acid and glycolysis product levels measured in the basal ganglia of the rat. Dev Brain Res 104:19-30
18. Cowan F, Rutherford M, Groenendaal F, Eken P, Mercuri E, Bydder GM, Meiners LC, Dubowitz LMS, de Vries LS (2003) Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet 361:736-742
19. Dell'Anna E, Chen Y, Engidawork E, Andersson K, Lubec G, Luthman J, Herrera-Marschitz M (1995) Short-term effects of perinatal asphyxia studied with Fos-inmunocytochemistry and in vivo microdialysis in the rat. Exp Neurol 131:279-287
20. Dell'Anna E, Chen Y, Engidawork E, Andersson K, Lubec G, Luthman J, Herrera-Marschitz M (1997) Delayed neuronal death following perinatal asphyxia in rat. Exp Brain Res 115:105-115
21. De Murcia G, Schreiber V, Molinete M, Saulier B, Poch O, Masson M, Niedergang C, Menesier de Murcia J (1994) Structure and function of poly(ADP-ribose) polymerase. Mol Cell Biochem 138:15-24
22. Ducrocq S, Benjelloun N, Plotkine M, Ben-Ari Y, Charriaut-Marlangue C (2000) Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem 74:2504-2511
23. Eliasson MJ, Sampei K, Madier AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH (1997) Poly(ADP-ribose) Polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3:1089-1095
24. Engidawork E, Loidl F, Chen Y, Kohlhauser C, Stoeckler S, Dell'Anna, Lubec G, Goiny M, Gross J, Andersson K, Herrera-Marschitz M (2001) Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia. Exp Brain Res 138:375-383
25. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferreiro DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicenter randomised trial. Lancet 365:663-670
26. Gross J, Müller I, Chen Y, Elizade M, Leclere N, Herrera-Marschitz M, Andersson K (2000) Perinatal asphyxia induces region-specific long-term changes in mRNA levels of tyrosine hydroxylase and dopamine D1 and D2 receptors in rat brain. Brain Res Mol Brain Res 79:110-117
27. Gross J, Andersson K, Chen Y, Müller I, Andreeva N, Herrera-Marschitz M (2005) Effect of perinatal asphyxia on tyrosine hydroxylase and D2 and D1 dopamine receptor mRNA levels expressed during early postnatal development in rat brain. Mol Brain Res 134:275-281
28. Gunn AJ, Cook CJ, Williams CE, Johnston BM, Gluckman PD (1991) Electrophysiological responses of the fetus to hypoxia and asphyxia. J Dev Physiol 16:147-153
29. Gunn AJ, Thoressen M (2006) Hypothermic neuroprotection. NeuroRx 3:154-169
30. Haddad GG, Jiang C (1993) O2 deprivation in the central nervous system: on the mechanisms of neuronal response, differential sensitivity and injury. Prog Neurobiol 40:277-318
31. Herrera-Marschitz M, Meana JJ, O'Connor WT, Goiny M, Reid MS, Ungerstedt U (1992) Neuronal dependence of extracellular, dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions. Amino Acids 2:157-179
32. Herrera-Marschitz M, Loidl CF, Andersson K, Silveira R, O'Connor WT, Goiny M (1994) Neurocircuitry of the basal ganglia studied by monitoring neurotransmitter release: effects of intracerebral and perinatal lesions. Mol Neurobiol 9:171-182
33. Herrera-Marschitz M, You Z-B, Goiny M, Meana JJ, Silveira R, Godukhin O, Chen Y, Espinoza S, Pettersson E, Loidl F, Lubec G, Andersson K, Nylander I, Terenius L, Ungerstedt U (1996) On the origin of extracellular glutamate levels monitored in the basal ganglia by in vivo microdialysis. J Neurochem 66:1726-1735
34. Hong SJ, Dawson TM, Dawson VL (2004) Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signalling. TIPS 25:259-264
35. Hurd J, Ungerstedt U (1989) Calcium dependency of amphetamine, nomifensine and Lu 19-005 effects on dopamine transmission. Eur J Pharmacol 166:261-270
36. Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S (2004) A novel and potent Poly(ADP-Ribose) Polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H0- pyridinyl)propyl]-4(3H)-quinazolinone) attenuates neuronal damage in vitro and in vivo models of cerebral ischemia. J Pharmacol Exp Ther 310:425-436
37. Jiang B-H, Rue E, Wang GL, Roe R, Semenza GL (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271:17771-17778
38. Kamanaka Y, Kondo K, Ikeda Y, Kamoshima W, Kitajima T, Suzuki Y, Nakamura Y, Umemura K (2004) Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage. Life Sci 76:151-162
39. Kihara S, Shiraishi T, Nakagawa S, Toda K, Tabuchi K (1994) Visualization of DNA double strand breaks in the gerbil hippocampal CA1 following transient ischemia. Neurosci Lett 175:133-136
40. Klawitter V, Morales P, Johansson S, Bustamante D, Goiny M, Gross J, Luthman J, Herrera-Marschitz (2005) Effect of perinatal asphyxia on cell survival, neuronal phenotype and neurite growth evaluated with organotypic triple cultures. Amino Acids 28:149-155
41. Kohlhauser C, Mosgoeller W, Hoeger H, Lubec G, Lubec B (1999a) Cholinergic, monoaminergic and glutamatergic changes following perinatal asphyxia in the rat. Cell Mol Life Sci 55:1491-1501
42. Kohlhauser C, Kaehler S, Mosgoeller W, Singewald N, Kouvelas D, Prast H, Hoeger H, Lubec B (1999b) Histological changes and neurotransmitter levels three months following perinatal asphyxia in the rat. Life Sci 64:2109-2124
43. Loidl CF, Herrera-Marschitz M, Anderson K, You Z-B, Goiny M, O'Connor WT, Silveira R, Rawal R, Bjelke B, Chen Y, Ungerstedt U (1994) Long-term effects of perinatal asphyxia on basal ganglia neurotransmitter systems studied with microdialysis in rat. Neurosci Lett 175:9-12
44. Low JA (2004) Determining the contribution of asphyxia to brain damage in the neonate. J Obstet Gynaecol Res 30:276-286
45. Lupton BA, Hill A, Roland EH, Withfield M, Flodmark O (1988) Brain swelling in the asphyxiated term newborn: pathogenesis and outcome. Pediatrics 82:139-146
46. Miller SP, Ramaswamy V, Michelson D, Barkovich J, Holshouser B, Wycliff N, Glidden DV, Deming D, Partridge JC, Wu YW, Ashwal S, Ferreiro DM (2005) Patterns of brain injury in term neonatal encephalopathy. J Pediatr 146:453-460
47. Morales P, Klawitter V, Johansson S, Huaiquin P, Barros VG, Avalos AM, Fiedler J, Bustamante D, Gomez-Urquijo S, Goiny M, Herrera-Marschitz M (2003) Perinatal asphyxia impairs connectivity and dopamine neurite branching in organotypic triple culture from rat substantia nigra. Neurosci Lett 348:175-179
48. Nakajima H, Kakui N, Ohkuma K, Ishikawa M, Hasegawa T (2005) A newly synthesized Poly(ADP-Ribose) Polymerase inhibitor, DR2313[2-methyl-3,5,7,8- tetrahydrothiopyranol[ 4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects and therapeutic time window in cerebral ischemia in rats. J Pharmacol Exp Ther 312:472-481
49. Pasternak JF, Predey TA, Mikhael MA (1991) Neonatal asphyxia: vulnerability of basal ganglia, thalamus and brain stem. Pediatr Neurol 7:147-149
50. Pastuzko A (1994) Metabolic responses of the dopaminergic system during hypoxia in newborn brain. Biochem Med Metab Biol 51:1-15
51. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
52. Pusinelli WA, Brierley JB, Plum F (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491-498
53. Roland EH, Poskitt K, Rodriguez E, Lupton BA, Hill A (1998) Perinatal hypoxic-ischemia thalamic injury: clinical features and neuroimaging. Ann Neurol 44:161-166
54. Sakakibara Y, Mitha AP, Ogilvy CS, Maynard KI (2000) Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar rats. Neurosci Lett 281:111-114
55. Takahashi K, Pieper AA, Croul SE, Zhang J, Snyder SH, Greenberg JH (1999) Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res 829:46-54
56. Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathway in the rat brain. Acta Physiol Scand Suppl 367:1-48
57. Ungerstedt U, Herrera-Masrschitz M, Jungnelius U, Ståhle L, Tossman U, Zetterström (1982) Dopamine synaptic mechanisms reflected in studies combining behavioural recordings and brain dialysis. Adv Biosci 37:219-231
58. Ungethüm U, Chen Y, Gross J, Bjelke B, Bolme P, Eneroth P, Heldt J, Loidl CF, Herrera-Marschitz M, Andersson K (1996) Effects of perinatal asphyxia on the mesostriatal/mesolimbic dopamine system of neonatal and 4-week-old male rats. Exp Brain Res 112:403-410
59. Vannuci SJ, Hagberg H (2004) Hypoxia-ischemia in the immature brain. J Exp Biol 207:3149-3154
60. Venkatesan A, Frucht S (2006) Movement disorders after resuscitation from cardiac arrest. Neurol Clin 24:123-132
61. Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429
62. Volpe J (2001) Neurology of the newborn, 4th edn. WB Saunders Company, Philadelphia, PA
63. Wan FJ, Lin HC, Kang BH, Tseng CJ, Tung CS (1999) D-amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment. Brain Res Bull 50:167-171
64. Yan Q, Briehl M, Crowley CL, Payne CM, Bernstein H, Bernstein C (1999) The NAD+ precursors, nicotinic acid and nicotinamide upregulate glyceraldehyde-3-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase mRNA in Jurkat cells. Biochem Biophys Res Commun 255:133-136
65. Ying W, Alano CC, Garnier P, Swanson RA (2005) NAD+ as a metabolic link between DNA damage and cell death. J Neurosci Res 79:216-223
66. Yu SW, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GC, Dawson TM, Dawson VL (2002) Mediation of poly(ADP-ribose) polymerase-1 dependent cell death by apoptosis-inducing factor. Science 297:250-263
67. Zetterström T, Sharp T, Marsden C, Ungerstedt U (1983) In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after D-amphetamine. J Neurochem 41:1769-1773
68. Zhang J, Pieper A, Snyder SH (1995) Poly(ADP-ribose) synthase activation: an early indicator of neurotoxic DNA damage. J Neurochem 65:1411-1414